Physician

Anita K. Patel, M.D.

According to 2025 Medicare claims, Anita Patel, M.D. (NPI: 1144398694) practices nephrology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH SYSTEM (NPI: 1891702833; TIN: 38-1357020) and primary practice location at 48202-2608. Patel is affiliated with the Mosaic ACO (ACO ID: A5033) and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 108 traditional Medicare patients, billed 960 HCPCS/CPT codes, and received $50,734 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 769 prescription claims across 157 beneficiaries totaling $41,695 in drug costs, led by Tacrolimus (Tacrolimus). DME data shows 750 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $62,181 to $50,734. Similarly, Part D prescription costs have fallen sharply in recent years, from $172,704 to $41,695. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	345	760	$62,181
2016	344	676	$54,644
2017	320	632	$51,553
2018	225	1,482	$50,177
2019	162	416	$35,589
2020	165	436	$36,279
2021	134	427	$31,814
2022	173	377	$36,822
2023	139	334	$31,685
2024	108	960	$50,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	240	1,330	$172,704
2016	303	1,826	$214,518
2017	378	2,657	$389,567
2018	455	3,580	$592,381
2019	358	2,071	$324,523
2020	191	1,060	$118,097
2021	148	889	$92,085
2022	145	799	$166,596
2023	152	929	$181,450
2024	157	769	$41,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	478	2,051	$217,786
2016	466	2,146	$198,853
2017	740	3,339	$434,377
2018	941	5,404	$635,340
2019	687	3,337	$359,451
2020	314	1,450	$184,409
2021	236	1,130	$81,909
2022	195	1,071	$55,460
2023	218	1,000	$48,270
2024	159	750	$42,542

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	17	17	$166
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	79	$108
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	12	12	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	16	42	$95
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	26	64	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tacrolimus	Tacrolimus	15	1,350	$7,325
Cinacalcet Hcl	Cinacalcet Hcl	16	795	$5,039
Nifedipine Er	Nifedipine	61	4,538	$2,360
Prednisone	Prednisone	90	7,306	$887
Labetalol Hcl	Labetalol Hcl	14	1,200	$810

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	47	$18,274
J7527	Everolimus, oral, 0.25 mg	N	N/R	11	$7,814
J7515	Cyclosporine, oral, 25 mg	N	N/R	32	$4,254
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	46	235	$2,821
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	48	144	$2,503

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Anita K. Patel, M.D.?

Tedicare shows public-source Medicare data for Anita K. Patel, M.D. (NPI 1144398694), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anita K. Patel, M.D. have ACO affiliation data?

Anita K. Patel, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033) and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Anita K. Patel, M.D.?

Anita K. Patel, M.D. is linked to HENRY FORD HEALTH SYSTEM (billing NPI 1891702833) in the available physician profile data.

Does Anita K. Patel, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.